Literature DB >> 22302350

Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.

Xiang Jiao1, Laura D Wood, Monica Lindman, Sian Jones, Phillip Buckhaults, Kornelia Polyak, Saraswati Sukumar, Hannah Carter, Dewey Kim, Rachel Karchin, Tobias Sjöblom.   

Abstract

Exome sequencing of human breast cancers has revealed a substantial number of candidate cancer genes with recurring but infrequent somatic mutations. To determine more accurately their mutation prevalence, we performed a mutation analysis of 36 novel candidate cancer genes in 96 human breast cancers. Somatic mutations with potential impact on protein function were observed in the genes ADAM12, CENTB1, CENTG1, DIP2C, GLI1, GRIN2D, HDLBP, IKBKB, KPNA5, NFKB1, NOTCH1, and OTOF. These findings strengthen the evidence for involvement of the Notch, Hedgehog, NF-KB, and PIK3CA pathways in breast cancer development, and point to novel processes that likely are involved.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302350      PMCID: PMC3302210          DOI: 10.1002/gcc.21935

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  28 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

Review 2.  Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Authors:  James D Brenton; Lisa A Carey; Ahmed Ashour Ahmed; Carlos Caldas
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

3.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

Authors:  Philip Stephens; Sarah Edkins; Helen Davies; Chris Greenman; Charles Cox; Chris Hunter; Graham Bignell; Jon Teague; Raffaella Smith; Claire Stevens; Sarah O'Meara; Adrian Parker; Patrick Tarpey; Tim Avis; Andy Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin Teh; Siu T Yuen; Andrew G Nicholson; Sunil Lakhani; Douglas F Easton; Barbara L Weber; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Nat Genet       Date:  2005-05-22       Impact factor: 38.330

4.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

5.  Identification of Notch1 as a frequent target for provirus insertional mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse mammary tumor virus.

Authors:  S Yanagawa; J S Lee; K Kakimi; Y Matsuda; T Honjo; A Ishimoto
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation.

Authors:  Jesus K Yamamoto-Furusho; Nicolas Barnich; Ramnik Xavier; Tadakazu Hisamatsu; Daniel K Podolsky
Journal:  J Biol Chem       Date:  2006-09-27       Impact factor: 5.157

7.  RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.

Authors:  Kathryn M Goolsby; David J Shapiro
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

8.  Identification of an amplified, highly expressed gene in a human glioma.

Authors:  K W Kinzler; S H Bigner; D D Bigner; J M Trent; M L Law; S J O'Brien; A J Wong; B Vogelstein
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

Review 9.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

10.  Aberrant activation of notch signaling in human breast cancer.

Authors:  Spyros Stylianou; Rob B Clarke; Keith Brennan
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

View more
  37 in total

1.  Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.

Authors:  Ann Marie Egloff; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2012-07-06       Impact factor: 12.531

2.  Notch1 single nucleotide polymorphism rs3124591 is associated with the risk of development of invasive ductal breast carcinoma in a Chinese population.

Authors:  Yu-Wen Cao; Guo-Xing Wan; Chun-Xia Zhao; Jian-Ming Hu; Li Li; Wei-Hua Liang; Wen-Qin Li; Yu-Cong Li; Yi-Xiao Li; Xiao-Ming Du; Shi-Ying Yu; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Mouse and human Notch-1 regulate mucosal immune responses.

Authors:  D R Mathern; L E Laitman; Z Hovhannisyan; D Dunkin; S Farsio; T J Malik; G Roda; A Chitre; A C Iuga; G Yeretssian; M C Berin; S Dahan
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

4.  Association of Genetic Variants in NF-kB with Susceptibility to Breast Cancer: a Case Control Study.

Authors:  Rabeb M Ghali; Sana Mahjoub; Sonia Zaied; Hanen Bhiri; Wael Bahia; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-07-19       Impact factor: 3.201

5.  Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.

Authors:  Emelia A Assar; Magdalena Castellano Vidalle; Mridula Chopra; Sassan Hafizi
Journal:  Tumour Biol       Date:  2016-01-16

6.  Competing views on cancer.

Authors:  Carlos Sonnenschein; Ana M Soto; Annapoorni Rangarajan; Prakash Kulkarni
Journal:  J Biosci       Date:  2014-04       Impact factor: 1.826

7.  Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.

Authors:  Kim De Keersmaecker; Zeynep Kalender Atak; Ning Li; Carmen Vicente; Stephanie Patchett; Tiziana Girardi; Valentina Gianfelici; Ellen Geerdens; Emmanuelle Clappier; Michaël Porcu; Idoya Lahortiga; Rossella Lucà; Jiekun Yan; Gert Hulselmans; Hilde Vranckx; Roel Vandepoel; Bram Sweron; Kris Jacobs; Nicole Mentens; Iwona Wlodarska; Barbara Cauwelier; Jacqueline Cloos; Jean Soulier; Anne Uyttebroeck; Claudia Bagni; Bassem A Hassan; Peter Vandenberghe; Arlen W Johnson; Stein Aerts; Jan Cools
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

Review 8.  Karyopherins in cancer.

Authors:  Tolga Çağatay; Yuh Min Chook
Journal:  Curr Opin Cell Biol       Date:  2018-02-04       Impact factor: 8.382

Review 9.  Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.

Authors:  Libero Santarpia; Giulia Bottai; Catherine M Kelly; Balázs Győrffy; Borbala Székely; Lajos Pusztai
Journal:  Oncologist       Date:  2016-07-06

10.  Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.

Authors:  Bochuan Zhang; Qingfeng Wang; Chenghao Fu; Chunying Jiang; Shiliang Ma
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.